Journals / Tüberküloz ve Toraks / 2006 / Cilt: 54 - Sayı: 3

The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease

Kronik obstrüktif akciğer hastalığında yaşam kalitesinin belirlenmesinde SF-36 sağlık taramasının değeri

Pages
259–266
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The SF-36 general quality of life questionnaire is a useful measurement instrument for the evaluation of therapeutic efficiency and follow up of COPD patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study was performed in chronic obstructive pulmonary disease (COPD) patients to compare the SF-36 questionnaire with pulmonary function tests and non-functional parameters.
📊
Key Findings & Data:Fourty-five COPD patients diagnosed according to GOLD 2004 criteria were included in the study.
💡
Conclusion & Impact:The SF-36 general quality of life questionnaire is a useful measurement instrument for the evaluation of therapeutic efficiency and follow up of COPD patients.
🔬Design:Survey & Empirical Study
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

This study was performed in chronic obstructive pulmonary disease (COPD) patients to compare the SF-36 questionnaire with pulmonary function tests and non-functional parameters. Fourty-five COPD patients diagnosed according to GOLD 2004 criteria were included in the study. The stable patients were evaluated by spirometry, static lung volumes, diffusion capacity, 6 MWD, BORG scale, MMRC dyspnea measurement and SF-36 life questionnaire performed on the same day. The mean age of the patients was 66 ± 10 years and the female/male ratio was 4/41. The mean FEV1/FVC ratio was 0.49 (moderate COPD n= 18, severe COPD n= 27). The RV/TLC ratio was 0.52. Walking distance was less than normal, with a mean of 375 ± 119 m. All the SF-36 scale except pain index are low compared to normal. General health perceptions, physical functioning, role physical, role emotional, social functioning, energy and mental health index are as follows: 47 ± 24, 50 ± 30, 35 ± 38, 49 ± 37, 63 ± 33, 49 ± 20, 59 ± 20, respectively. When the general health scale compared with FVC and FEV1 revealed moderate correlation was found (r= 0.56, r= 0.55, respectively). Physical functioning compared with FVC, FEV1, RV/TLC and IC revealed moderate correlation (r= 0.62, r= 0.67, r= -0.54, r= 0.65, respectively). General health and physical functioning scales correlated with the non-functional parameters (MMRC, 6 MWD) (r= -0.51, r= 0.53, r= -0.61, r= 0.64 respectively). The SF-36 general quality of life questionnaire is a useful measurement instrument for the evaluation of therapeutic efficiency and follow up of COPD patients.

Özet

Bu çalışma, kronik obstrüktif akciğer hastalığı (KOAH) olan hastalarda “Short Form (SF)-36” yaşam kalitesi anketinin, fonksiyonel ve nonfonksiyonel parametrelerle uyumlu olup olmadığını araştırmak amacıyla yapılmıştır. GOLD 2004 kriterlerine göre KOAH tanısı konmuş, orta ve ağır dereceli 45 hasta çalışmaya alınmıştır. Stabil durumdaki bu hastaların, aynı gün içinde spirometrik muayeneleri, akciğer volümleri, difüzyon kapasiteleri, altı dakika yürüme mesafesi (6 DYM), BORG skalası, “modified medical research council dyspnea scale (MMRC)” dispne ölçümü yapılarak, SF-36 genel yaşam kalitesi anketi uygulanmıştır. Hastaların yaş ortalaması 66 ± 10 olup, kadın/erkek oranı 4/41’dir. Tüm hastaların FEV1/FVC ortalaması 0.49’dur (orta dereceli 18, ağır dereceli 27 hasta). Bu hastaların rezidüel volüm (RV)/total akciğer kapasitesi (TLC) oranı 0.52’dir. Yürüme mesafeleri, normalden düşük olup, ortalaması 375 ± 119 m’dir. SF-36’nın ağrı dışındaki tüm skala skorları normale göre düşüktür. Genel sağlık, fiziksel fonksiyon, fiziksel rol, emosyonel rol, sosyal fonksiyon, enerji ve mental sağlık skala skorları sırasıyla; 47 ± 24, 50 ± 30, 35 ± 38, 49 ± 37, 63 ± 33, 49 ± 20, 59 ± 20 olarak bulunmuştur. Genel sağlık skalası, FVC ve FEV1 ile orta dereceli ve anlamlı korelasyon göstermiştir (sırasıyla r= 0.56, r= 0.55). Fiziksel fonksiyon skalası ise FVC, FEV1, RV/TLC ve inspiratuar kapasite (IC) ile orta dereceli ve anlamlı korelasyon göstermiştir (sırasıyla r= 0.62, r= 0.67, r= -0.54, r= 0.65). Bu skalalar, benzer şekilde, nonfonksiyonel parametrelerden MMRC ve 6 DYM ile orta dereceli ve anlamlı korelasyon göstermiştir (sırasıyla r= -0.51, r= 0.53, r= -0.61, r= 0.64). Ağır KOAH hastalarında, orta dereceli olanlara göre genel sağlık, fiziksel fonksiyon, sosyal fonksiyon ve enerji skalaları anlamlı derecede düşüktür. Sonuç olarak, SF-36 genel yaşam kalitesi anketi, KOAH’lı hastaların izlenmesinde ve tedavi etkinliğinin değerlendirilmesinde kullanılabilecek bir ölçüm yöntemidir.

🔖

Cite This Article

SOYYİĞİT, Ş., KILINÇ, G., ERK, M., GÜLER, N. (2022). The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease. Tüberküloz ve Toraks, Cilt: 54 - Sayı: 3, 259–266. https://ajindex.com/articles/619136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Mahler DA. How should health related quality of life be assessed in patients with COPD? Chest 2000; 117: 54-7
  2. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-Item questionnaire to measure health-related quality of life patients with COPD. Chest 1995; 107: 1585-9
  3. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107: 187-93
  4. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: Reliability and validity in a patient population. Med Care 1988; 26: 724-35
  5. Ware JE JR, Sherbourne CD. The MOS 36- item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83
  6. Boueri FMV, Bucher-Bartelson BL, Glenn KA, Make BJ. Quality of life measured with a generic instrument (Short Form-36) ımproves following pulmonary rehabilitation in patients with COPD. Chest 2001; 119: 77-84
  7. McHorney CA, Ware JE, Rogers W, et al. The validity and relative precision of MOS short and long form health status and Dartmouth COOP charts: Results from the Medical Outcomes Study. Med Care 1992; 30: 253-65
  8. Global Initiative For Chronic Obstructive Lung Disease. Pocket Guide to COPD Diagnosis, Management and Prevention. A Guide for Physicians and Nurses. Based on NHLBI/WHO Workshop Report Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease. National Institutes of Health. National Heart, Lung and Blood Institute. Updated 2004
  9. Hansel TT, Barnes PJ. An atlas of chronic obstructive pulmonary disease (COPD). Resource for reference, teaching and lecturing 2004: 84
  10. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36
  11. European Community for Steel and Coal. Standardized Lung Function Testing. Eur Respir J 1993; 6: 1-100
  12. Mahler DA, Carolyn K. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-6
  13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-7
  14. Borg GAV. Phsycophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81
  15. Şenocak M. Biyoistatistik. İstanbul: İstanbul Üniversitesi Tıp Fakültesi Yayınları, 1998
  16. Fan V, Curtis JR, MacDowell M, Fihn SD. Using quality of life to predict hospitalizations and death in chronic obstructive lung disease. Chest 2002; 122: 429-36
  17. Ferreira CAS, Stelmach